| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...876651L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0076651 |
| P932 | PMC publication ID | 3788746 |
| P698 | PubMed publication ID | 24098546 |
| P5875 | ResearchGate publication ID | 257465042 |
| P2093 | author name string | Lei Wang | |
| Ying Su | |||
| Jinling Liu | |||
| Shenggang Sun | |||
| Peng Yan | |||
| Jiangchuan Dong | |||
| P2860 | cites work | A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group | Q64955097 |
| Network meta-analysis for indirect treatment comparisons | Q74720205 | ||
| Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study | Q83139326 | ||
| Measurement in clinical trials: a neglected issue for statisticians? | Q83864364 | ||
| Treatment of depressive symptoms in Parkinson's disease | Q37831398 | ||
| The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review | Q37841542 | ||
| Depression in Parkinson disease--epidemiology, mechanisms and management. | Q37971293 | ||
| Psychosocial interventions for depression and anxiety in Parkinson's disease | Q38018015 | ||
| Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond | Q40580469 | ||
| Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone? | Q43069007 | ||
| Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease | Q43938508 | ||
| Placebo in clinical trials for depression: complexity and necessity | Q43951893 | ||
| SSRIs in the treatment of depression in Parkinson's disease | Q44467578 | ||
| Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. | Q44489208 | ||
| Does Nefazodone Improve Both Depression and Parkinson Disease? A Pilot Randomized Trial | Q44603295 | ||
| Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients? | Q46192764 | ||
| Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study | Q46724727 | ||
| Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life. | Q53247825 | ||
| Active placebos versus antidepressants for depression | Q24247474 | ||
| Therapies for depression in Parkinson's disease | Q24248733 | ||
| Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials | Q27691373 | ||
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. | Q30419918 | ||
| The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease | Q33607256 | ||
| Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease | Q33647691 | ||
| The placebo response in Parkinson's disease. Parkinson Study Group | Q33708267 | ||
| Simultaneous comparison of multiple treatments: combining direct and indirect evidence. | Q34081552 | ||
| Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease | Q34086449 | ||
| Provisional diagnostic criteria for depression of Alzheimer disease | Q34121328 | ||
| Placebo response in studies of major depression: variable, substantial, and growing | Q34122652 | ||
| Effects of expectation on placebo-induced dopamine release in Parkinson disease | Q34129314 | ||
| Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review | Q34204924 | ||
| Placebos and painkillers: is mind as real as matter? | Q34431140 | ||
| Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial | Q34619438 | ||
| Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions | Q34743030 | ||
| Systematic review of antidepressant therapies in Parkinson's disease. | Q35595715 | ||
| A comparison of nine scales to detect depression in Parkinson disease: which scale to use? | Q35846532 | ||
| Antidepressant studies in Parkinson's disease: a review and meta-analysis | Q36008775 | ||
| Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample | Q36026290 | ||
| Prevalence and treatment of depression in Parkinson's disease | Q36265386 | ||
| Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group | Q36279999 | ||
| Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
| Contribution of spontaneous improvement to placebo response in depression: a meta-analytic review | Q36432995 | ||
| Evaluation of networks of randomized trials | Q36966424 | ||
| Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke | Q37113067 | ||
| A controlled trial of antidepressants in patients with Parkinson disease and depression | Q37180389 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | e76651 | |
| P577 | publication date | 2013-10-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis | |
| P478 | volume | 8 |
| Q64861761 | Antidepressants for Depression, Apathy, and Gait Instability in Parkinson's Disease: A Multicenter Randomized Study |
| Q35559180 | Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis |
| Q36925905 | Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease |
| Q47319471 | Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis |
| Q33765388 | Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis |
| Q41684008 | Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications |
| Q92582995 | Management of Depression in Parkinson's Disease: A Systematic Review |
| Q28066691 | Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases |
| Q39323947 | New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease |
| Q52311656 | Patterns and Predictors of Depression Treatment among Older Adults with Parkinson's Disease and Depression in Ambulatory Care Settings in the United States. |
| Q38266818 | Pramipexole extended-release: a review of its use in patients with Parkinson's disease |
| Q38588201 | Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders. |
| Q34574771 | Psychiatric aspects of Parkinson's disease |
| Q29994860 | Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson's Disease |
| Q28078546 | The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease |
| Q36494212 | The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease |
| Q55645561 | Treatment of advanced Parkinson's disease. |
| Q31136171 | Using Canadian Primary Care Sentinel Surveillance Network data to examine depression in patients with a diagnosis of Parkinson disease: a retrospective cohort study |
| Q53797704 | [Depression in old age, part 2 : Comorbidity and treatment]. |
Search more.